We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.08%
2 Financials 6.03%
3 Industrials 5.01%
4 Consumer Discretionary 4.73%
5 Healthcare 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANIK icon
5601
CALL
Anika Therapeutics
ANIK
$287M
$464K ﹤0.01%
8,600
+4,300
+100% +$238K
ENOV icon
5602
CALL
Enovis
ENOV
$1.53B
$464K ﹤0.01%
6,798
-3,544
-34% -$239K
WAT icon
5603
CALL
Waters Corp
WAT
$39.9B
$464K ﹤0.01%
2,400
IMPV
5604
CALL
DELISTED
Imperva, Inc.
IMPV
$464K ﹤0.01%
11,700
-13,100
-53% -$546K
BHVN
5605
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$464K ﹤0.01%
+17,200
New +$474K
ANAB icon
5606
CALL
AnaptysBio
ANAB
$1.68B
$463K ﹤0.01%
+4,600
New +$339K
BRZU icon
5607
CALL
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$97.7M
$463K ﹤0.01%
329
+160
+95% +$230K
CMPR icon
5608
Cimpress
CMPR
$2.31B
$462K ﹤0.01%
+3,850
New +$442K
WSBC icon
5609
WesBanco
WSBC
$4B
$462K ﹤0.01%
11,358
-14,124
-55% -$577K
NTUS
5610
CALL
DELISTED
Natus Medical Inc
NTUS
$462K ﹤0.01%
12,100
-6,200
-34% -$248K
BRFS
5611
PUT
DELISTED
BRF SA
BRFS
$461K ﹤0.01%
40,900
+30,700
+301% +$392K
VIA
5612
DELISTED
Viacom Inc. Class A
VIA
$461K ﹤0.01%
+13,209
New +$438K
LGF.B
5613
CALL
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$460K ﹤0.01%
14,500
+1,600
+12% +$48K
PBCT
5614
PUT
DELISTED
People's United Financial Inc
PBCT
$460K ﹤0.01%
24,600
+12,900
+110% +$239K
QADA
5615
DELISTED
QAD Inc.
QADA
$460K ﹤0.01%
11,842
-908
-7% -$34.1K
BCC icon
5616
Boise Cascade
BCC
$3.02B
$459K ﹤0.01%
11,513
-12,157
-51% -$451K
CMRX
5617
DELISTED
Chimerix, Inc.
CMRX
$458K ﹤0.01%
98,936
-66,554
-40% -$317K
ENZ
5618
DELISTED
Enzo Biochem, Inc.
ENZ
$458K ﹤0.01%
56,241
+43,678
+348% +$417K
SIL icon
5619
CALL
Global X Silver Miners ETF NEW
SIL
$4.75B
$457K ﹤0.01%
14,000
-10,900
-44% -$349K
GFI icon
5620
CALL
Gold Fields
GFI
$36.5B
$456K ﹤0.01%
106,100
-96,000
-48% -$387K
PNFP icon
5621
Pinnacle Financial Partners Inc
PNFP
$15.8B
$456K ﹤0.01%
6,883
-236,711
-97% -$15.7M
TWOU
5622
DELISTED
2U Inc
TWOU
$456K ﹤0.01%
236
-161
-41% -$302K
CYH icon
5623
CALL
Community Health Systems
CYH
$423M
$455K ﹤0.01%
106,700
+7,900
+8% +$39.7K
HOFT icon
5624
Hooker Furnishings Corp
HOFT
$166M
$455K ﹤0.01%
10,721
+3,071
+40% +$143K
PSC icon
5625
Principal Exchange-Traded Funds Principal US Small-Cap ETF
PSC
$2.3B
$455K ﹤0.01%
14,335
-1,606
-10% -$49.4K

Similar funds

Citadel Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Citadel Advisors opened 1,440 new positions and closed 988 in Q4 2017.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.